For an early-stage life science company, collaboration with a larger corporation can be the perfect alternative to equity financing and provide advantages along your path to clinical validation. But a huge component of a successful deal and a healthy partnership depends on the term sheet, and as an entrepreneur you want to make sure you’re setting yourself up for success.
Johnson & Johnson Innovation, JLABS (JLABS) is bringing together a panel of experts to provide you with insights and a forum to learn everything you’ve always wanted to know about the partnering process and term sheets. A Johnson & Johnson Innovation transactions leader, an IP transactions expert and two entrepreneurs who’ve been through the partnering process will share their experiences and knowledge on topics including:
∙ Pros and cons of equity funding vs. collaboration
∙ How collaborating can impact your path to clinical validation
∙ What to look out for in the collaboration process
∙ Variation in types of deals and agreements
∙ Critical deal terms
∙ And more!